News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Merck Frosst Canada Welcomes Health Canada Scientific Advisory Panel On COX-2 Inhibitors



10/19/2005 5:13:04 PM

MONTREAL, April 18 /CNW/ - Merck Frosst recognizes as an important public health matter, the safety profile of the selective COX-2 inhibitors and NSAID classes. As such, the Company welcomes recent announcements from Health Canada that it will convene a scientific advisory panel to evaluate selective COX-2 inhibitors later this spring.

Read at Canada NewsWire


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES